Isoprinosine
CAS No. 36703-88-5
Isoprinosine( Inosine pranobex | NP 113 | NPT 10381 )
Catalog No. M14262 CAS No. 36703-88-5
Isoprinosine has a number of immunomodulatory effects, including inducing T-lymphocyte differentiation, augmenting macrophage and NK cell functions, and stimulating IL-2 production.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 500MG | 38 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameIsoprinosine
-
NoteResearch use only, not for human use.
-
Brief DescriptionIsoprinosine has a number of immunomodulatory effects, including inducing T-lymphocyte differentiation, augmenting macrophage and NK cell functions, and stimulating IL-2 production.
-
DescriptionIsoprinosine has a number of immunomodulatory effects, including inducing T-lymphocyte differentiation, augmenting macrophage and NK cell functions, and stimulating IL-2 production. Through these effects and others, isoprinosine shows antiviral activity and has applications against subacute sclerosing panencephalitis. It also restores depressed immune responses in Y patients after irradiation and reduces the incidence of infection in leukemia patients undergoing chemotherapy. It is most commonly used to treat the rare measles complication subacute sclerosing panencephalitis in conjunction with intrathecal interferon therapy.
-
In Vitro——
-
In Vivo——
-
SynonymsInosine pranobex | NP 113 | NPT 10381
-
PathwayApoptosis
-
TargetIL Receptor
-
RecptorIL-2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number36703-88-5
-
Formula Weight1115.23
-
Molecular FormulaC52H78N10O17
-
Purity>98% (HPLC)
-
SolubilitySoluble in Water
-
SMILESCC(CN(C)C)O.CC(CN(C)C)O.CC(CN(C)C)O.CC(=O)NC1=CC=C(C=C1)C(=O)O.CC(=O)NC1=CC=C(C=C1)C(=O)O.CC(=O)NC1=CC=C(C=C1)C(=O)O.C1=NC(=O)C2=C(N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Beran J, et al. BMC Infect Dis. 2016; 16: 648.
molnova catalog
related products
-
ARRY-797
ARRY-797 is a potent and selective p38α inhibitor and inhibits LPS-Induced IL-6.
-
Vunakizumab
Vunakizumab (Anti-Human IL17A Recombinant Antibody) is a human IgGκ monoclonal antibody that specifically targets and inhibits IL-17A's receptor interaction, making it useful for researching autoimmune conditions such as psoriatic arthritis, ankylosing spondylitis, multiple sclerosis, and inflammatory arthritis .
-
Resiniferatoxin
Resiniferatoxin inhibits the production of Th1 cytokines, contributing to the defense against T. spiralis infection, and can be used in studies about the modulator of the immune response.
Cart
sales@molnova.com